NCT06934837

Brief Summary

The aim of this study is to evaluate the mylohyoid, geniohyoid and digastric muscles in patients with radiotherapy-induced dysphagia due to nasopharynx cancer using ultrasonography and shear wave elastography (SWE).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2025

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 18, 2025

Completed
Last Updated

April 18, 2025

Status Verified

April 1, 2025

Enrollment Period

5 months

First QC Date

April 6, 2025

Last Update Submit

April 12, 2025

Conditions

Keywords

DysphagiaNasopharynx cancerSWESwallowing disorders

Outcome Measures

Primary Outcomes (3)

  • Swallowing muscle thickness

    Right and left digastric - mylohyoid muscle thickness, as well as geniohyoid thickness using ultrasonography and Shear Wave Elastography. The thickness values of the mylohyoid, geniohyoid and digastric muscles were measured in mm by experienced radiologist.

    12 months after radiotherapy.

  • Swallowing muscle pressure

    Right and left digastric - mylohyoid muscle pressure, as well as geniohyoid pressure using ultrasonography and Shear Wave Elastography. The outcome pressure is measured in kPA by an experienced radiologist .

    12 months after radiotherapy.

  • Swallowing muscle velocity

    Right and left digastric - mylohyoid muscle velocity, as well as geniohyoid velocity using ultrasonography and Shear Wave Elastography. The velocity values of the mylohyoid, geniohyoid and digastric muscles were measured in m/s by an experienced radiologist.

    12 months after radiotherapy.

Study Arms (2)

Nasopharynx canser (disease group)

16 Stage I nasopharynx cancer patients receiving radiotherapy

Control (healthy) group

16 healthy volunteers from the otorhinolaryngology outpatient clinic

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

18 or older than 65 years receiving radiotherapy, presented with dysphagia.

You may qualify if:

  • Patient Group:
  • Volunteered for the study.
  • Aged 18-65 years.
  • Diagnosed with Stage I nasopharynx cancer.
  • Completed radiotherapy treatment at least 12 months prior to the study.
  • No additional cancer diagnoses.
  • No history of chemo-radiotherapy.
  • No prior head-neck trauma or surgery.
  • No rheumatologic or neuromuscular disorders.
  • No pre-existing swallowing disorders.
  • Control Group (Healthy Volunteers):
  • Control group:
  • Aged 18-65 years.
  • No history of head and neck cancer.
  • No prior neck surgery or trauma.
  • +4 more criteria

You may not qualify if:

  • Younger than 18 years or older than 65 years.
  • Any history of neck interventions (e.g., for cancer metastasis, cervical spine surgery, trauma).
  • Presence of systemic conditions potentially causing dysphagia (e.g., neurological, rheumatological, metabolic, or muscular disorders).
  • Previous radiotherapy for reasons other than Stage I nasopharynx cancer (in the patient group).
  • Any other cancer diagnosis besides Stage I nasopharynx cancer (in the patient group).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selçuk University Faculty of Medicine Hospital

Konya, 42020, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Deglutition DisordersNasopharyngeal Neoplasms

Condition Hierarchy (Ancestors)

Esophageal DiseasesGastrointestinal DiseasesDigestive System DiseasesPharyngeal DiseasesOtorhinolaryngologic DiseasesPharyngeal NeoplasmsOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsNasopharyngeal DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 6, 2025

First Posted

April 18, 2025

Study Start

January 1, 2023

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

April 18, 2025

Record last verified: 2025-04

Locations